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Substance use
disorder overview

Normal detoxification
with benzodiazepines

Introduction

Significance of the
problem

Purpose
Project
purpose, goals,
and aims

For providers and nurses to better understand the severity
of their patient’s drug use habits and adequately assess for
the presence of polysubstance use on admission to an
inpatient facility

Goal

Reduce use of benzodiazepines to improve the overall
withdrawal experience

Aim

Reduce unnecessary benzodiazepine use in patients
undergoing medical detoxification from illicit substances,
not including alcohol by the end of three months of the
study

Theoretical
base

 Evidence Based Practice Improvement (EBPI) model
 Developed in 2010 and combines two existing
paradigms: evidence-based practice and process
improvement

PICOT
question

In individuals experiencing drug detoxification,
how does utilizing the Drug Abuse Screening Test
to analyze drug use upon admission compared to
no assessment affect use of benzodiazepines for
detoxification symptoms within length of stay at
an inpatient psychiatric hospital?

Literature
search
strategy

Validity of screening
tools for patients with
substance use disorder

Current
literature

• Drug Abuse
Screening Test
• Substance Use Risk
Profile Scale
• Identification of
substance use
disorder

Medical detoxification
treatments with
benzodiazepines
• Symptom triggered
scales
• Tapered
benzodiazepines

Methods: Setting/
Participants

 Substance use and dual diagnosis unit in a psychiatric hospital
 Patients aged 18 years and older

 Initial chart review three times weekly for four weeks

Methods:
Data
collection

 Evaluated categories: number of patients present on the
unit, substances present in a drug screen, if benzodiazepine
treatment was being utilized and what type, age, gender,
admitting doctor, and readmission within 30 days status
 Consent unnecessary because data was de-identified
 Education provided to nurses and providers regarding Drug
Abuse Screening Test for one month
 Chart review completed again for four weeks

Methods:
outcome
measures

If an overall reduction in the number of
benzodiazepines used for detoxification was
seen

Data collected and stored in a Microsoft excel table
with each line dictating a single patient
• For yes/no questions, 1 indicated yes and 0 indicated no

Methods: Data
analysis

Chi-square test was completed to evaluate if there
was a relationship between the two main variables:
time before and after screening tool implementation

Stratification of data occurred to remove duplicates

Results:
demographics

180 patients
pre-screening
and 134
patients postscreening

Average age
of the patient
was 38

71.7% male
and 28.3%
female

Average
length of stay
at time of
assessment
was 2.43 days

Substance Tested

Pre-screening
Post-screening
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Results: Substances used
Positive Drug Screens
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65 patients had a blood
alcohol level greater
than 0, 50 having a BAL
greater than 0.05

Average BAL > 0 was
0.051, average BAL for
> 0.05 was 0.233

40 patients negative on
both UDS and BAL (12
did not have one
completed)

Results: Substances Used

Results:
Benzodiazepine
use

 As needed benzodiazepines showed a statistically
significant chi-square value of 0.004 – 27.8% were
prescribed as-needed benzodiazepines during time 1
and 10.6% were prescribed as-needed
benzodiazepines during time 2
 Scheduled and tapered benzodiazepines did not show
a statistically significant chi-square value for reduction
of use

 Confirmed the use of the drug abuse screening test was
associated with a decrease in benzodiazepine use on a
detoxification unit

Discussion

 As needed benzodiazepines showed a statistically
significant decrease of prescribing between time 1 and time
2, indicating that the drug abuse screening tool likely had
some effect in the ordering of benzodiazepines
 Confirms that using a screening tool to address drug use
can accurately assess drug use and assist in appropriate
benzodiazepine use for patients

 Appropriate use of benzodiazepines can lower sedation
rates and reduce exposure to addictive substances
 Limitations include small sample size at only one facility, not
thorough education for providers, and ultimate prescribing
authority of the provider

Implications and
Limitations
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